- Home
- BGR vs SRDX Comparison
BGR vs SRDX Comparison
Compare BGR & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGR
- SRDX
- Stock Information
- Founded
- BGR 2004
- SRDX 1979
- Country
- BGR United States
- SRDX United States
- Employees
- BGR N/A
- SRDX N/A
- Industry
- BGR Trusts Except Educational Religious and Charitable
- SRDX Medical/Dental Instruments
- Sector
- BGR Finance
- SRDX Health Care
- Exchange
- BGR Nasdaq
- SRDX Nasdaq
- Market Cap
- BGR 350.6M
- SRDX 415.4M
- IPO Year
- BGR N/A
- SRDX 1998
- Fundamental
- Price
- BGR $13.47
- SRDX $32.38
- Analyst Decision
- BGR
- SRDX Buy
- Analyst Count
- BGR 0
- SRDX 3
- Target Price
- BGR N/A
- SRDX $43.00
- AVG Volume (30 Days)
- BGR 73.3K
- SRDX 318.4K
- Earning Date
- BGR 01-01-0001
- SRDX 11-05-2025
- Dividend Yield
- BGR 6.02%
- SRDX N/A
- EPS Growth
- BGR N/A
- SRDX N/A
- EPS
- BGR 0.69
- SRDX N/A
- Revenue
- BGR N/A
- SRDX $120,801,000.00
- Revenue This Year
- BGR N/A
- SRDX N/A
- Revenue Next Year
- BGR N/A
- SRDX $3.38
- P/E Ratio
- BGR $18.97
- SRDX N/A
- Revenue Growth
- BGR N/A
- SRDX N/A
- 52 Week Low
- BGR $11.38
- SRDX $26.00
- 52 Week High
- BGR $13.37
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- BGR 52.85
- SRDX 35.24
- Support Level
- BGR $13.34
- SRDX $34.00
- Resistance Level
- BGR $13.69
- SRDX $34.74
- Average True Range (ATR)
- BGR 0.14
- SRDX 1.41
- MACD
- BGR 0.01
- SRDX -0.57
- Stochastic Oscillator
- BGR 56.86
- SRDX 2.66
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.